Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.59 |
| ▸ | CASP3 | P42574 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.51 |
| ▸ | TNF | P01375 | 1/20 | 0.51 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL118169 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL18359346 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL29398498 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL29367434 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL29440768 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL1228254 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL29349650 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| SCHEMBL30291593 | 1.00 | MDM4 (0.59) | MDM4TP53CASP3KMT2AMDM2 | |
| Ammonia Solution, Strong SCHEMBL27827995 | 0.99 | MDM4 (0.58) | MDM4TP53CASP3KMT2AMDM2 | |
| Fluoride SCHEMBL7153172 | 0.99 | MDM4 (0.58) | MDM4TP53CASP3KMT2AMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115561372-B | Method for detecting related substances in N-fluorenylmethoxycarbonyl-L-phenylalanine | 重庆莱美隆宇药业有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119684406-A | Enzyme response self-assembled polypeptide prodrug loaded with camptothecine, preparation and application thereof | 东南大学 | 2025-03-25 | — | — | CN | claimed |
| CN-117567554-B | Gel factor and hydrogel loaded with anti-inflammatory agent as well as preparation methods and application thereof | 中国科学技术大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119192295-A | Neurostatin cyclic peptide and preparation method and application thereof | 西北师范大学 | 2024-12-27 | — | — | CN | claimed |
| CN-118750438-A | Carbamazepine supermolecule hydrogel and preparation method, characterization method and application thereof | 山东大学 | 2024-10-11 | — | — | CN | claimed |
| CN-116920010-B | Preparation method of Yupingfeng compound traditional Chinese medicine preparation | 江西新世纪民星动物保健品有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-115521362-B | Preparation method of Pseudodestruxin B | 哈尔滨工业大学（深圳） | 2024-05-28 | — | — | CN | claimed |
| CN-117924414-A | Compound for promoting Abeta clearance and preparation method and application thereof | 中山大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117659117-A | Preparation method of short peptide hydrogel and infrared spectrum analysis method for in-situ characterization of short peptide assembly dynamics process | 山东大学 | 2024-03-08 | — | — | CN | claimed |
| EP-3423569-B1 | 3D PRINTING OF A CELLULARISED SCAFFOLD | UNIV OXFORD INNOVATION LTD (GB) | 2024-02-21 | — | — | EP | claimed |
| EP-1700244-A4 | A METHOD FOR DESIGNING SURFACES | BIO LAYER PTY LTD (AU) | 2009-07-08 | — | — | EP | claimed |
| EP-1685134-B1 | NOVEL CHELIDONINE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF FOR PRODUCING PHARMACEUTICAL AGENTS | SALAMA ZOSER B NAT RER DR (DE) | 2009-02-11 | — | — | EP | claimed |
| CN-101177259-A | Method for preparing primary amine carbon nano tube | UNIV TONGJI (CN) | 2008-05-14 | — | — | CN | claimed |
| US-20080039483-A1 | Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents | SALAMA ZOSER B | 2008-02-14 | — | — | US | claimed |
| US-20070099235-A1 | Method for designing surfaces | BIO-LAYER PTY LIMITED (AU) | 2007-05-03 | — | — | US | claimed |
| EP-1700244-A1 | A METHOD FOR DESIGNING SURFACES | Bio-Layer Pty Limited (AU) | 2006-09-13 | — | — | EP | claimed |
| EP-1685134-A1 | NOVEL CHELIDONINE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF FOR PRODUCING PHARMACEUTICAL AGENTS | Salama, Zoser B. nat.rer.Dr. (DE) | 2006-08-02 | — | — | EP | claimed |
| WO-2005057462-A1 | A METHOD FOR DESIGNING SURFACES | BIO-LAYER PTY LIMITED (AU) | 2005-06-23 | — | — | WO | claimed |
| WO-2005044820-A1 | NOVEL CHELIDONINE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF FOR PRODUCING PHARMACEUTICAL AGENTS | SALAMA ZOSER B (DE) | 2005-05-19 | — | — | WO | claimed |
| CN-1490330-A | Production of acetooxdralpeptide | 上海子能高科股份有限公司 | 2004-04-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039483-A1 | Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents | KIT, MKI67, MCL1 | MDM4 3248/4885TP53 49/4885CASP3 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.